Though in some cases tumor regression was obtained by adoptive transfer of TIL [22] or tumor specific antigen vaccines [23,24], tumor responses have also been achieved using immunostimulatory cytokines and antibodies that block immunosuppressive signals, e.g. CTLA4 [25-28]. The gene discussed is CTLA4; the disease is neoplasm.